151 related articles for article (PubMed ID: 2654533)
1. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
[TBL] [Abstract][Full Text] [Related]
2. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.
Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
Microb Pathog; 1987 Jul; 3(1):21-30. PubMed ID: 3143036
[TBL] [Abstract][Full Text] [Related]
3. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
[TBL] [Abstract][Full Text] [Related]
4. Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea.
Ohmura M; Cao C; Karasawa T; Okuda J; Kurazono H; Gannon VP; Gyles CL; Takeda Y
Microb Pathog; 1993 Nov; 15(5):399-405. PubMed ID: 8015420
[TBL] [Abstract][Full Text] [Related]
5. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.
Lindgren SW; Samuel JE; Schmitt CK; O'Brien AD
Infect Immun; 1994 Feb; 62(2):623-31. PubMed ID: 8300218
[TBL] [Abstract][Full Text] [Related]
6. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
MacLeod DL; Gyles CL
Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
[TBL] [Abstract][Full Text] [Related]
8. Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli O157:H7.
Ito H; Yutsudo T; Hirayama T; Takeda Y
Microb Pathog; 1988 Sep; 5(3):189-95. PubMed ID: 3063913
[TBL] [Abstract][Full Text] [Related]
9. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome.
Ito H; Terai A; Kurazono H; Takeda Y; Nishibuchi M
Microb Pathog; 1990 Jan; 8(1):47-60. PubMed ID: 2185397
[TBL] [Abstract][Full Text] [Related]
10. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.
Weinstein DL; Jackson MP; Samuel JE; Holmes RK; O'Brien AD
J Bacteriol; 1988 Sep; 170(9):4223-30. PubMed ID: 3045088
[TBL] [Abstract][Full Text] [Related]
11. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
Yutsudo T; Honda T; Miwatani T; Takeda Y
Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II.
Downes FP; Green JH; Greene K; Strockbine N; Wells JG; Wachsmuth IK
J Clin Microbiol; 1989 Jun; 27(6):1292-7. PubMed ID: 2666439
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
[TBL] [Abstract][Full Text] [Related]
14. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
[TBL] [Abstract][Full Text] [Related]
15. Purification of recombinant shiga-like toxin type I B subunit.
Austin PR; Hovde CJ
Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
[TBL] [Abstract][Full Text] [Related]
16. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
Weinstein DL; Jackson MP; Perera LP; Holmes RK; O'Brien AD
Infect Immun; 1989 Dec; 57(12):3743-50. PubMed ID: 2807546
[TBL] [Abstract][Full Text] [Related]
17. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the Shiga-like toxin produced by Escherichia coli associated with porcine edema disease.
Gannon VP; Gyles CL
Vet Microbiol; 1990 Jul; 24(1):89-100. PubMed ID: 2219668
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the antigenic difference between Vero toxin 2 (VT2) and VT2 variant (VT2vh) of Verotoxin-producing Escherichia coli by a site-directed mutagenesis.
Ito H; Nishibuchi M; Takeda Y
FEMS Microbiol Lett; 1991 Mar; 63(1):27-30. PubMed ID: 2044938
[TBL] [Abstract][Full Text] [Related]
20. Effects of human intravenous immune globulin on diarrhea caused by Shiga-like toxin I and Shiga-like toxin II in infant rabbits.
Havens PL; Dunne WM; Burd EM
Microbiol Immunol; 1992; 36(10):1077-85. PubMed ID: 1479962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]